Compatibility and safety of five lectin-binding putative probiotic strains for the development of a multi-strain protective culture for poultry

Benef Microbes. 2018 Dec 7;9(6):927-935. doi: 10.3920/BM2017.0199. Epub 2018 Aug 13.

Abstract

The ban on the use of antibiotics as feed additives for animal growth promotion in the European Union and United States and the expectation of this trend to further expand to other countries in the short term have prompted a surge in probiotic research. Multi-species probiotics including safe and compatible strains with the ability to bind different nutritional lectins with detrimental effects on poultry nutrition could replace antibiotics as feed additives. Lactobacillus salivarius LET201, Lactobacillus reuteri LET210, Enterococcus faecium LET301, Propionibacterium acidipropionici LET103 and Bifidobacterium infantis CRL1395 have proved to be compatible as evaluated through three different approaches: the production and excretion of antimicrobial compounds, growth inhibition by competition for essential nutrients and physical contact, and a combination of both. The safety of P. acidipropionici LET103 was confirmed, since no expression of virulence factors or antibiotic resistance was detected. The innocuity of E. faecium LET301 should be further evaluated, since the presence of genes coding for certain virulence factors (gelE, efaAfm and efaAfs) was observed, albeit no expression of gelE was previously detected for this strain and there are no reports of involvement of efaAfm in animal pathogenicity. Finally, a combination of the five strains effectively protected intestinal epithelial cells of broilers from the cytotoxicity of mixtures of soybean agglutinin, wheat germ agglutinin and concanavalin A. To our knowledge, this is the first time that a combination of strains is evaluated for their protection against lectins that might be simultaneously present in poultry feeds.

Keywords: agglutinins; antibiotic ban; feed additives; poultry.

MeSH terms

  • Animals
  • Anti-Infective Agents / metabolism*
  • Antibiosis
  • Bifidobacterium longum subspecies infantis / genetics
  • Bifidobacterium longum subspecies infantis / growth & development
  • Bifidobacterium longum subspecies infantis / metabolism*
  • Bifidobacterium longum subspecies infantis / pathogenicity
  • Cell Line
  • Cell Survival / drug effects
  • Concanavalin A / toxicity
  • Drug Resistance, Bacterial
  • Enterococcus faecium / genetics
  • Enterococcus faecium / growth & development
  • Enterococcus faecium / metabolism*
  • Enterococcus faecium / pathogenicity
  • Epithelial Cells / drug effects
  • Epithelial Cells / physiology
  • Lactobacillus / genetics
  • Lactobacillus / growth & development
  • Lactobacillus / metabolism*
  • Lactobacillus / pathogenicity
  • Lectins / metabolism
  • Models, Theoretical
  • Plant Lectins / toxicity
  • Poultry Diseases / prevention & control*
  • Probiotics / adverse effects
  • Probiotics / pharmacology*
  • Propionibacterium / genetics
  • Propionibacterium / growth & development
  • Propionibacterium / metabolism*
  • Propionibacterium / pathogenicity
  • Protein Binding
  • Soybean Proteins / toxicity
  • Virulence
  • Virulence Factors / genetics
  • Wheat Germ Agglutinins / toxicity

Substances

  • Anti-Infective Agents
  • Lectins
  • Plant Lectins
  • Soybean Proteins
  • Virulence Factors
  • Wheat Germ Agglutinins
  • soybean lectin
  • Concanavalin A